Work

In vivo disposition of irinotecan (CPT-11) and its metabolites in combination with the monoclonal antibody cetuximab.

Year: 2006

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: Dagmar E Ettlinger, Markus Mitterhauser, Wolfgang Wadsak, Eva Ostermann, André Farkouh, Johann Schueller, Martin Czejka

Institution: University of Vienna

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2172204877

FWCI: 0.675

Cites: 14

Cited by: 17

Related to: 10